https://www.theglobeandmail.com/business/article-can-canadas-psychedelic-drug-developers-shake-off-the-sectors-bad-trip/
psychedelic use still problematic as Canada and USA only allow very few studies to take place, even tho recent report saw great potential, authorities are quibbling about methodologies....
#psychedelics, #endoflifeclosure, #fearoftheunknown, #spiritualexperience

Can Canada’s psychedelic drug developers shake off the sector’s bad trip?
Cybin, MindMed are set to launch expanded human studies after recent trial setbacks for Lykos, Compass
The Globe and Mail